An invertebrate mdm homolog interacts with p53 and is differentially expressed together with p53 and ras in neoplastic Mytilus trossulus haemocytes

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 156, Issue 4, 2010, Pages 298-308

  Muttray, Annette F ^a   O'Toole, Teagan F ^b   Morrill, Wendy ^b   Van Beneden, Rebecca J ^b   Baldwin, Susan A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MAINE   (United States)

Author keywords

Bivalve; Cancer; Haemic neoplasia; Mdm2; Mytilus; P53; Ras

Indexed keywords

DNA HOMOLOG; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; CONTROLLED STUDY; GENE SEQUENCE; GENETIC TRANSCRIPTION; MOLECULAR CLONING; MUSSEL; MYTILUS TROSSULUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION;

BIVALVIA; INVERTEBRATA; MOLLUSCA; MYTILUS; MYTILUS TROSSULUS; VERTEBRATA;

EID: 77954865637     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2010.04.008     Document Type: Article

References (49)

1. Barber B.J. Neoplastic diseases of commercially important marine bivalves. Aquat. Living Resour. 2004, 17:449-466.
2. Benner S.A., Cohen M.A., Gonnet G.H. Amino acid substitution during functionally constrained divergent evolution of protein sequences. Protein Eng. 1994, 7:1323-1332.
3. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 1989, 49:4682-4689.
4. Böttger S., Jerszyk E., Low B., Walker C. Genotoxic stress-induced expression of p53 and apoptosis in leukemic clam hemocytes with cytoplasmically sequestered p53. Cancer Res. 2008, 68:777-782.
5. Bower, S.M., 2006. Synopsis of infectious diseases and parasites of commercially exploited shellfish: haemocytic neoplasia of mussels. Last accessed: October 20, 2009. http://www.pac.dfo-mpo.gc.ca/science/species-especes/shellfish-coquillages/diseases-maladies/pages/hcnmu-eng.htm.
6. Calabro V., Mansueto G., Parisi T., Vivo M., Calogero R.A., La Mantia G. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J. Biol. Chem. 2002, 277:2674-2681.
7. Ciocan C.M., Moore J.D., Rotchell J.M. The role of ras gene in the development of haemic neoplasia in Mytilus trossulus. Mar. Environ. Res. 2006, 62:S147-S150.
8. Cox R.L., Stephens R.E., Reinisch C.L. p63/73 homologues in surf clam: novel signaling motifs and implications for control of expression. Gene 2003, 320:49-58.
9. Fernandes A.D., Atchley W.R. Biochemical and functional evidence of p53 homology is inconsistent with molecular phylogenetics for distant sequences. J. Mol. Evol. 2008, 67:51-67.
10. Friday B.B., Adjei A.A. K-ras as a target for cancer therapy. Biochim. Biophys. Acta (BBA) - Rev. Cancer: KRAS Oncogene 2005, 1756:127-144.
11. Gietz D., St.Jean A., Woods R.A., Schiestl R.H. Improved method for high-efficiency transformation of intact yeast cells. Nucleic Acids Res. 1992, 20:1425.
12. Goldberg E.D. The mussel watch - a first step in global marine monitoring. Mar. Pollut. Bull. 1975, 6:111.
13. Golemis E.A., Serebriiskii I., Finely R.L., Kolonin M.G., Gyuris J., Brent R. Interaction trap/two-hybrid system to identify interacting proteins. Analysis of Protein-Protein Interactions, Current Protocols in Protein Science 1998, 19.2.1-19.2.40. Wiley, USA. J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
14. Goodson M.S., Crookes-Goodson W.J., Kimbell J.R., McFall-Ngai M.J. Characterization and role of p53 family members in the symbiont-induced morphogenesis of the Euprymna scolopes light organ. Biol. Bull. 2006, 211:7-17.
15. ras brings a new twist to the regulation of p73 by Mdm2. Sci. STKE 2006, 337:pe24.
16. Harms K., Nozell S., Chen X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 2004, 61:822-842.
17. Harris S.L., Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899-2908.
18. Holbrook L.A.C., Butler R.A., Cashon R.E., Van Beneden R.J. Soft-shell clam (Mya arenaria) p53: a structural and functional comparison to human p53. Gene 2009, 433:81-87.
19. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420:25-27.
20. Huang Q., Raya A., DeJesus P., Chao S.-H., Quon K.C., Caldwell J.S., Chanda S.K., Izpisua-Belmonte J.C., Schultz P.G. Identification of p53 regulators by genome-wide functional analysis. Proc. Natl Acad. Sci. USA 2004, 101:3456-3461.
21. Jeong M.H., Bae J., Kim W.H., Yoo S.M., Kim J.W., Song P.I., Choi K.H. p19ras interacts with and activates p73 by involving the MDM2 protein. J. Biol. Chem. 2006, 281:8707-8715.
22. Kelley M.L., Winge P., Heaney J.D., Stephens R.E., Farell J.H., Van Beneden R.J., Reinisch C.L., Lesser M.P., Walker C.W. Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer. Oncogene 2001, 20:748-758.
23. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., Pavletich N.P. Structure of the Mdm2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996, 274:948-953.
24. Lane D.P., Cheok C.F., Brown C.J., Madhumalar A., Ghadessy F.J., Verma C. The Mdm2 and p53 genes are conserved in the Arachnids. Cell Cycle 2010, 9:748-754.
25. Levrero M., De Laurenzi V., Costanzo A., Gong J., Wang J., Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci. 2000, 113:1661-1670.
26. Lin J., Chen J., Elenbaas B., Levine A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 1994, 8:1235-1246.
27. Linke K., Mace P.D., Smith C.A., Vaux D.L., Silke J., Day C.L. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 2008, 15:841-848.
28. Lu W.J., Abrams J.M. Lessons from p53 in non-mammalian models. Cell Death Differ. 2006, 13:909-912.
29. Marchler-Bauer A., Anderson J.B., Derbyshire M.K., DeWeese-Scott C., Gonzales N.R., Gwadz M., Hao L., He S., Hurwitz D.I., Jackson J.D., Ke Z., Krylov D., Lanczycki C.J., Liebert C.A., Liu C., Lu F., Lu S., Marchler G.H., Mullokandov M., Song J.S., Thanki N., Yamashita R.A., Yin J.J., Zhang D., Bryant S.H. CDD: a conserved domain database for interactive domain family analysis. Nucl. Acids Res. 2007, 35:D237-D240.
30. Marine J.-C., Jochemsen A.G. Mdmx as an essential regulator of p53 activity. Biochem. Biophys. Res. Com. 2005, 331:750-760.
31. Marine J.-C., Francoz S., Maetens M., Wahl G., Toledo F., Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006, 13:927-934.
32. Meek D.W., Knippschild U. Posttranslational modification of MDM2. Mol. Cancer Res. 2003, 1:1017-1026.
33. Michael D., Oren M. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 2002, 12:53-59.
34. Munger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 1989, 63:4417-4421.
35. Murray-Zmijewski F., Lane D.P., Bourdon J.-C. p53/63/73 isoforms: an orchestra of isoforms to harmonize cell differentiation and response to stress. Cell Death Differ. 2006, 13:962-972.
36. Muttray A.F., Cox R.L., St-Jean S.D., van Poppelen P., Reinisch C.L. Identification and phylogenetic comparison of p53 in two distinct mussel species (Mytilus). Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 2005, 140:237-250.
37. Muttray A.F., Cox R.L., Reinisch C.L., Baldwin S.A. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues. Mar. Biotechnol. 2007, 9:217-230.
38. Muttray A.F., Schulte P.M., Baldwin S.A. Invertebrate p53-like mRNA isoforms are differentially expressed in mussel haemic neoplasia. Mar. Environ. Res. 2008, 66:412-421.
39. Page R.D.M. TREEVIEW: an application to display phylogenetic trees on personal computers. Comp. Appl. Biosci. 1996, 12:357-358.
40. Picksley S.M., Vojtesek B., Sparks A.K., Lane D. Immunochemical analysis of the interaction of p53 with MDM2: fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 1994, 9:2523-2529.
41. Rice P., Longden I., Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000, 16:276-277.
42. Schiestl R.H., Gietz D. High-efficiency transformation of intact yeast cells using nucleic acids as a carrier. Curr. Genet. 1989, 16:339-346.
43. Schmale H., Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997, 15:1363-1367.
44. Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R.V., Lozano G., Oren M., Haupt Y. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 1999, 18:1805-1814.
45. Walker C.W., Böttger S. A naturally occurring cancer with molecular connectivity to human diseases. Cell Cycle 2008, 7:1-3.
46. Walker C., Bottger S.A., Mulkern J., Jerszyk E., Litvaitis M., Lesser M. Mass culture and characterization of tumor cells from a naturally occurring invertebrate cancer model: applications for human and animal disease and environmental health. Biol. Bull. 2009, 216:23-39.
47. Yang A., Kaghad M., Caput D., McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002, 18:90-95.
48. Ying H., Chang D.L.F., Zheng H., McKeon F., Xiao Z.-X.J. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol. Cell. Biol. 2005, 25:6154-6164.
49. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.